• Journal of cardiology · Aug 2007

    [Prevention of contrast-induced nephropathy using cardiac catheterization combined with hydration, oral N-acetylcysteine, sodium bicarbonate and iso-osmolar contrast agents].

    • Atsushi Hoshino, Satoko Enomoto, Hiroyuki Kawahito, Hiroyuki Kurata, Yoshifumi Nakahara, and Takashi Nakamura.
    • Department of Cardiology, Saiseikai Shiga Hospital, Shiga. a-hoshi@koto.kpu-m.ac.jp
    • J Cardiol. 2007 Aug 1; 50 (2): 119-26.

    ObjectivesContrast-induced nephropathy (CIN) after coronary angiography is a serious complication with an unfavorable prognosis. If CIN is persistent in the chronic phase, the prognosis is much worsened. We evaluated the efficacy of a new clinical therapy consisting of cardiac catheterization combined with hydration, oral N-acetylcysteine, sodium bicarbonate and iso-osmolar contrast agents.MethodsThe clinical therapy was applied to patients with pre-existent chronic renal insufficiency who underwent elective coronary angiography between December 2005 and December 2006. The incidence of CIN (defined as an increase > or = 25% and/or > or = 0.5 mg/dl in serum creatinine) persisting in the chronic phase at 30-60 days was examined in therapy era patients and compared with non-therapy era patients treated between January 2004 and November 2005, as well as patients with creatinine clearance < 40 ml/min.ResultsThe clinical therapy was applied to 31 of 517 consecutive patients who underwent coronary angiography. CIN persisting in the chronic phase at 30-60 days occurred in 28 of 808 consecutive non-therapy era patients and 8 of 517 consecutive therapy era patients (3.5% vs 1.8%, p < 0.05). Excluding emergent cases, it occurred in 23 of 752 non-therapy era patients and 5 of 466 therapy era patients (3.1% vs 1.1%, p < 0.05). The patients with pre-existent chronic renal insufficiency (creatinine clearance < 40 ml/min) included 66 non-therapy era patients, and 21 of 31 therapy patients. Serum creatinine increased in the non-therapy era group (p < 0.01), but not in the therapy group. CIN persisting in the chronic phase at 30-60 days occurred in 21 non-therapy era group but in none of the therapy group.ConclusionsTherapy for patients with renal failure consisting of cardiac catheterization combined with hydration, oral N-acetylcysteine, sodium bicarbonate and iso-osmolar contrast agents is effective to prevent CIN in the chronic phase.

      Pubmed     Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        

    hide…

What will the 'Medical Journal of You' look like?

Start your free 21 day trial now.

We guarantee your privacy. Your email address will not be shared.